Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Net Cash Flow (2022 - 2025)

Envoy Medical's Net Cash Flow history spans 4 years, with the latest figure at $183000.0 for Q4 2025.

  • Quarterly results put Net Cash Flow at $183000.0 for Q4 2025, down 82.74% from a year ago — trailing twelve months through Dec 2025 was -$1.7 million (down 237.67% YoY), and the annual figure for FY2025 was -$1.7 million, down 237.67%.
  • Net Cash Flow for Q4 2025 was $183000.0 at Envoy Medical, up from -$1.7 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $16.8 million in Q3 2023 to a low of -$12.6 million in Q4 2023.
  • The 4-year median for Net Cash Flow is -$22870.0 (2022), against an average of $175375.0.
  • Peak annual rise in Net Cash Flow hit 4189.71% in 2023, while the deepest fall reached 2904.76% in 2023.
  • Year by year, Net Cash Flow stood at -$420000.0 in 2022, then tumbled by 2904.76% to -$12.6 million in 2023, then surged by 108.4% to $1.1 million in 2024, then plummeted by 82.74% to $183000.0 in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at $183000.0, -$1.7 million, and -$23000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.